On 11 january, the beijing intellectual property court held a press conference to inform it of the high-quality development of its 2022 service capital. From the meeting, journalists were informed that the court had concluded a number of representative cases last year, including the ensorption of the ten world's anti-oncological medicines. In addition, the court continues to improve the quality of trials through mechanisms such as the establishment of the green channel, for various types of cases, such as the key core “calculated neck” technical case。
The press was informed at the launch that the court had actually received 33,750 cases last year, concluding 23757 cases and closing 360 cases per judge. In response to the increase in the number of cases received, the court has introduced 18 reform measures, including the elaboration of administrative procedures for the diversion of administrative cases, the intensification of pre- and post-trial matters, and the continuous improvement of the “multi-mediate mediation + quick fix”. “in 2022, more than 90 per cent of the trademark rejection cases were electronically delivered, 2 per cent were handled by summary procedures, 4275 cases were closed on an exclusive basis, the simplified procedure was realized without loss of rights, the pace of quality was not diminished, and additional judicial resources were released for difficult and complex cases. The vice president of the court introduced the song fish water。
In response to the key core technical cases of “calculated neck”, the beijing court established a fast-track, fast-track, sophisticated “green path” for priority cases, created a model of “four specializeds” for research, specialized sessions, expert guidance and the development of expertise, and concluded a number of high-value technical cases such as the “ten global anti-oncracies ensormamine patent case” “red foul eggs”. The beijing court also set up a special session to hear pharmaceutical patent-related cases, issued a guide to civil patent-related applications for registered medicines (pilot) in english, and efficiently concluded the first national drug-related patent-linking case, central and foreign pharmaceuticals v. Sea crane pharmaceuticals, as well as the case of sigletine two-aceles. In addition, in cases involving various fields, such as data protection, trademarks, competition monopolies, copyrights, etc., the beijing icj has concluded a number of representative cases。
Vice-president of the beijing intellectual property court
The vice-president of the beijing court of intellectual property stated that, in the future, the beijing court will further develop the delivery of precision justice services around the beijing city international centre for science, technology and innovation, promote institutional reform and strengthen judicial capacity. “we will continue to explore reforms such as pre-suit settlement of trademark administrative cases, improvement of post-judgement mechanisms, delivery mechanisms for foreign cases, and the clearance of procedural obstacles that have long plagued our court's proceedings. In addition, improvements will be made to the `four-professional' model for the development of intellectual property justice personnel in high places, in line with intellectual property law。
